Cross-talk of Ito(stellate) cell and preneoplastic and cancer cells of hepatocarcinogenesis
Cross-talk of Ito(stellate) cell and preneoplastic and cancer cells of hepatocarcinogenesis
批准号:
11670507
负责人:
SAKAIDA Isao
金额:
$2.11万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2002
中文摘要
我们在研究期间的发现如下:(1)胆碱缺乏L-氨基酸(CDAA)定义的饮食诱导肝细胞死亡和再生,导致星状细胞活化,导致肿瘤前病变周围纤维化。用抗纤维化剂例如脯氨酰4-羟化酶抑制剂治疗导致抑制星状细胞活化,从而预防肿瘤前病变,减少纤维化,而不保护细胞死亡。(2)用胆碱缺乏的L-氨基酸(CDAA)限定的饮食治疗大鼠诱导细胞死亡和再生,引起枯否细胞和星状细胞的活化,其将产生TGF-β 1,导致纤维化的持续。(3)将肝癌细胞培养上清加入星状细胞上可诱导MAP激酶通路的激活,而加入癌细胞上清对癌细胞的细胞周期无影响。星状细胞与癌细胞共培养表明星状细胞向癌细胞移动。这一结果可能表明星状细胞可以阻止癌细胞的侵袭。然而,还需要进一步的研究。(4)腺病毒介导的MAP激酶通路的激活揭示了MMP-9的表达主要受ERK通路的调控,而MMP-13的表达受P38通路的独立调控,这一结果将为肝纤维化的治疗和肿瘤转移机制的研究提供新的思路。
英文摘要
Our finding during investigation terms are as follows ;(1) Choline deficient L-amino acid (CDAA) defined diet induced hepatocyte cell death and regeneration resulting in stellate cell activation leading to preneoplastic lesions surrounded with fibrosis. Treatment with anti-fibrotic agent e.g. prolyl 4-hydrohylase inhibitor lead to the inhibition of stellate cell activation resulting in the prevention of preneoplastic lesions with reduced fibrosis without the protection of cell death.(2) Treatment rats with Choline deficient L-amino acid (CDAA) defined diet induced the cell death and regeneration causing the activation of Kupffer and stellate cells which will produce TGF-beta 1 resulting in the perpetuation of fibrosis.(3) Addition of the supernatant of cultured hepatic cancer cells on stellate cells induced activation of MAP kinase pathway but addition of the supernatant of stellate cells on cancer cells did not change the cell cycle of cancer cell. Co-culture of stellate cells and cancer cells indicated that the movement of stellate cells to cancer cells. This result may suggest the prevention of cancer cell invasion by stellate cells. However further studies are necessary.(4) The activation of MAP kinase pathway by using adenovirus system revealed that the expression of MMP-9 is regulated mainly by ERK pathway and MMP-13 is regulated by P38 pathway independently.These results will give the new insight for the therapy of liver fibrosis as well as the mechanism of cancer metastasis.
期刊论文(25)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Sakaida I, et al.,: "Correlation between stellate cell activation and serum fibrosis markers in choline-deficient L-amino acid-deflned diet-induced rat liver fibrosis."Dig Dis Sci. 45. 1935-1943 (2000)
Sakaida I 等人:“缺乏胆碱的 L-氨基酸饮食诱导的大鼠肝纤维化中星状细胞活化与血清纤维化标志物之间的相关性。”Dig Dis Sci。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Aoyagi N: "Prolyl 4-hydroxylase inhibitor is more effective for the inhibition of proliferation than for inhibition of collagen synthesis of rat hepatic stellate cells"Hepatology Research. 23. 1-6 (2002)
Aoyagi N:“脯氨酰4-羟化酶抑制剂对大鼠肝星状细胞增殖的抑制比对胶原合成的抑制更有效”肝病学研究。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Sakaida I et al.: "Loss of inhibitory growth regulation by TGF-β1 in preneoplastic lesions in rat liver."Dig.Dis.Sci.. (in press).
Sakaida I 等人:“大鼠肝脏癌前病变中 TGF-β1 抑制性生长调节的丧失。”Dig.Dis.Sci..(出版中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hironaka K,et al.: "Enhanced interstitial collagenase(matrix metalloproteinase-13) production of Kupffer cell by gadolinium chloride prevents pig serum-induced rat liver fibrosis in vivo."Biochem.Biophys.Res.Commun.. (in press).
Hironaka K 等人:“氯化钆增强库普弗细胞间质胶原酶(基质金属蛋白酶-13)的产生可预防猪血清诱导的体内大鼠肝纤维化。”Biochem.Biophys.Res.Commun.(正在出版)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Aoyagi M.: "Prolyl 4-hydroxylase inhibitor is more effective for the inhibition of proliferation than for inhibition of collagen synthesis of rat hepatic stellate cells"Hepatol Res.. 23. 1-6 (2002)
Aoyagi M.:“脯氨酰4-羟化酶抑制剂对于抑制大鼠肝星状细胞的增殖比抑制胶原合成更有效”Hepatol Res.. 23. 1-6 (2002)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 21 条
The development research of liver regeneration therapy used bone marrow drived liver repaired cell
-
批准号:20H03663
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.4万
-
财政年份:2020
-
负责人:SAKAIDA Isao
-
依托单位:
The development of liver regeneration therapy with higher therapeutic effects on liver cirrhosis using a middle-large size liver cirrhosis model.
-
批准号:17H04162
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.73万
-
财政年份:2017
-
负责人:SAKAIDA Isao
-
依托单位:
Development of new gene transfer system for small fish
-
批准号:22659148
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.04万
-
财政年份:2010
-
负责人:SAKAIDA Isao
-
依托单位:
Mechanism of fibrolysis and effect on cancer by autologus bone marrow cell infusion therapy for liver cirrhosis
-
批准号:19390199
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.73万
-
财政年份:2007
-
负责人:SAKAIDA Isao
-
依托单位:
The development of cell therapy for liver fibrolysis and prevention of carcinogenesis using bone marrow cell transplantaion
-
批准号:16590597
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2004
-
负责人:SAKAIDA Isao
-
依托单位:
Carcinogenesis and Ito cell
-
批准号:08670598
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1996
-
负责人:SAKAIDA Isao
-
依托单位:
海外基金